We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

75 hedge funds and large institutions have $494M invested in Epizyme, Inc in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 16

51% more capital invested

Capital invested by funds: $326M → $494M (+$168M)

25% more funds holding

Funds holding: 60 → 75 (+15)

7% more call options, than puts

Call options by funds: $876K | Put options by funds: $815K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
75
Holders Change
+15
Holders Change %
+25%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
32
Reduced
16
Closed
6
Calls
$876K
Puts
$815K
Net Calls
+$61K
Net Calls Change
+$61K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$53.1M
2
Primecap Management
Primecap Management
California
+$28.6M
3
JP Morgan Chase
JP Morgan Chase
New York
+$18M
4
Citigroup
Citigroup
New York
+$13.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13.1M

Top Sellers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
-$14.1M
2
DCM
Driehaus Capital Management
Illinois
-$4.84M
3
RFC
Russell Frank Company
Washington
-$2.77M
4
BC
Broadfin Capital
New York
-$2.08M
5
ARTA
A.R.T. Advisors
New York
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
26
BlackRock Institutional Trust
California
$1.92M +$486K +16,027 +24%
Northern Trust
27
Northern Trust
Illinois
$1.89M +$151K +4,989 +6%
Principal Financial Group
28
Principal Financial Group
Iowa
$1.68M +$2.24M +73,800 New
Axa
29
Axa
France
$1.66M +$2.21M +73,000 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.6M +$1.29M +42,614 +153%
TA
31
Teachers Advisors
New York
$1.47M +$275K +9,070 +16%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$1.21M +$1.62M +53,304 New
PA
33
Perceptive Advisors
New York
$1.2M +$1.59M +52,602 New
LCM
34
Laurion Capital Management
New York
$1.16M +$1.54M +50,900 New
TRSOTSOK
35
Teachers Retirement System of the State of Kentucky
Kentucky
$1.13M – – –
GTC
36
Ghost Tree Capital
New York
$1.02M +$1.36M +45,000 New
HTHT
37
Hemenway Trust Hemenway Trust
New Hampshire
$911K -$808K -26,666 -40%
Deutsche Bank
38
Deutsche Bank
Germany
$792K +$34.7K +1,145 +3%
ProShare Advisors
39
ProShare Advisors
Maryland
$726K +$576K +18,986 +147%
JMPWA
40
JP Morgan Private Wealth Advisors
California
$703K +$935K +30,856 New
FSA
41
Franklin Street Advisors
North Carolina
$644K +$6.06K +200 +0.7%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$609K +$15.9K +525 +2%
HT
43
HAP Trading
New York
$579K +$770K +25,415 New
BCB
44
Brian C. Broderick
$569K -$758K -25,000 -50%
CS
45
Credit Suisse
Switzerland
$559K -$621K -20,496 -46%
TCIM
46
TIAA CREF Investment Management
New York
$517K -$29.7K -980 -4%
Macquarie Group
47
Macquarie Group
Australia
$455K – – –
BIM
48
BlackRock Investment Management
Delaware
$426K +$69.2K +2,283 +14%
Charles Schwab
49
Charles Schwab
California
$397K +$140K +4,605 +36%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$387K +$515K +17,000 New
1
2
3 4

EPZM Hedge Fund Activity: Q1 2014 in Review

75 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2014, worth a combined $494M — up 51% from $326M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new EPZM positions and 6 closed out — a net gain of 15 holders — while 32 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $53.1M. The largest seller was MPM Asset Management, cutting an estimated $14.1M.

  • 75 institutional investors held Epizyme, Inc (EPZM) as of Q1 2014, up from 60 in Q4 2013.
  • Funds reported $494M of Epizyme, Inc stock for Q1 2014, up 51% quarter-over-quarter.
  • 21 funds opened new Epizyme, Inc positions in Q1 2014 and 6 closed out, a net change of +15 holders.
  • The largest Epizyme, Inc buyer in Q1 2014 was Fidelity Investments, an estimated $53.1M added.
  • The largest Epizyme, Inc seller in Q1 2014 was MPM Asset Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q1 2014.